Skip to main content
. 2022 Dec 22;108(6):1348–1354. doi: 10.1210/clinem/dgac744

Table 1.

Sex-specific characteristics for study participantsa

Men (N = 635) Women (N = 510)
Age at baseline, mean (SD), y 44.1 (6.3) 46.9 (5.9)
BMI at baseline, mean (SD) 27.7 (4.1) 26.6 (5.8)
Obesity (BMI ≥ 30) at baseline, N (%) 211 (33) 153 (30)
Height at baseline, mean (SD), cm 177.6 (6.6) 164.2 (6.4)
Physical Activity Index at baseline, mean (SD) 38.1 (8.9) 36.4 (6.3)
Weight at baseline, mean (SD), kg 87.5 (14.5) 71.9 (16.4)
Diabetes status at baseline, N (%) 15 (2) 11 (2)
Estrogenic at baseline, N (%) NA 411 (81)
Estrogen replacement therapy at baseline, N (%) NA 56 (11)
Underwent menopausal transition, N (%) NA 178 (35)
Adiponectin at baseline, mean (SD)a, ng/mL 6.2 (4.0) 11.5 (5.8)
Interleukin-6 at baseline, mean (SD)a, pg/mL 1.8 (2.0) 2.1 (4.8)
VAT at baseline, mean (SD), cm3 1915.3 (836.7) 1157.9 (732.2)
VAT at follow-up, mean (SD), cm3 2876.4 (1347.9) 1540.4 (1044.3)
Difference in VAT: follow-up—baseline, mean (SD), cm3 961.1 (800.3) 382.5 (541.2)
Paraspinal muscle density (HU) at baseline, mean (SD) 41.6 (9.8) 36.8 (9.6)
Paraspinal muscle density (HU) at follow-up, mean (SD) 44.9 (8.7) 39.4 (9.9)
Difference in paraspinal muscle density (HU), mean (SD) 3.2 (6.7) 2.6 (6.8)

The numbers in the cell are the mean (SD) for quantitative variables and count (%) for qualitative variable.

Abbreviations: BMI, body mass index; HU, Hounsfield unit; NA, not applicable; VAT, visceral adipose tissue.

Measured approximately 6 years before initial VAT measurement.